solidbio.com (SLDB): Operatsion rentabellik

Solid Biosciences Inc. (SLDB) kompaniyasining korporativ logotipi

Solid Biosciences Inc. (SLDB) viral vektorlarni ishlab chiqarishda to'liq ravishda uchinchi tomon pudratchilariga tayanadi. Operatsion rentabellikni monitoring qilish ushbu xarajatlar dinamikasini aks ettiradi va qiymat 0.00 darajasida barqarorlashgan. Kompaniya shikastlangan genlarni almashtirish orqali mushak distrofiyasi uchun inqilobiy davolash usullarini ishlab chiqmoqda. Kuchli patent portfeli texnologik ustunlikni yaratadi va u klinik sinovlar yakunlangach, to'laqonli moliyaviy aktivga aylanadi.

SLDB: solidbio.com Sotuvning operatsion marjasi 04.07.2022 - 19.11.2026

SLDB (Solid Biosciences): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental baholanishi:Solid Corp, SLDB
solidbio.com asosiy tovari

Ushbu koeffitsiyent sotuvlar hajmi nisbatida xarajatlarni boshqarish samaradorligini matematik jihatdan belgilaydi. Operatsion marja soliqlar va foiz to'lovlarigacha bo'lgan asosiy biznesdan olingan foydaning umumiy daromadga nisbatan foiz ulushini ifodalaydi. Gen terapiyasini ishlab chiqayotgan Solid Biosciences (SLDB) uchun ushbu metrika dori vositalari tijoratlashtirilishidan oldingi klinik ishlab chiqish xarajatlarini aks ettiradi. Operatsion marjani tahlil qilish innovatsiyalarni moliyalashtirish modelining barqarorligini baholash imkonini beradi. Ushbu ko'rsatkichning pasayishi operatsion xarajatlarning ortayotganidan dalolat beradi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik